• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受骨髓龛启发的巨核细胞祖细胞的多相扩增,具有高多倍体化潜力。

Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential.

机构信息

Department of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois 60208, USA.

出版信息

Cytotherapy. 2010 Oct;12(6):767-82. doi: 10.3109/14653241003786148.

DOI:10.3109/14653241003786148
PMID:20482285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3077558/
Abstract

BACKGROUND AIMS

Megakaryopoiesis encompasses hematopoietic stem and progenitor cell (HSPC) commitment to the megakaryocytic cell (Mk) lineage, expansion of Mk progenitors and mature Mks, polyploidization and platelet release. pH and pO2 increase from the endosteum to sinuses, and different cytokines are important for various stages of differentiation. We hypothesized that mimicking the changing conditions during Mk differentiation in the bone marrow would facilitate expansion of progenitors that could generate many high-ploidy Mks.

METHODS

CD34+ HSPCs were cultured at pH 7.2 and 5% O2 with stem cell factor (SCF), thrombopoietin (Tpo) and all combinations of Interleukin (IL)-3, IL-6, IL-11 and Flt-3 ligand to promote Mk progenitor expansion. Cells cultured with selected cytokines were shifted to pH 7.4 and 20% O2 to generate mature Mks, and treated with nicotinamide (NIC) to enhance polyploidization.

RESULTS

Using Tpo + SCF + IL-3 + IL-11, we obtained 3.5 CD34+ CD41+ Mk progenitors per input HSPC, while increasing purity from 1% to 17%. Cytokine cocktails with IL-3 yielded more progenitors and mature Mks, although the purities were lower. Mk production was much greater at higher pH and pO2. Although fewer progenitors were present, shifting to 20% O2 /pH 7.4 at day 5 (versus days 7 or 9) yielded the greatest mature Mk production, 14 per input HSPC. NIC more than doubled the percentage of high-ploidy Mks to 40%.

CONCLUSIONS

We obtained extensive Mk progenitor expansion, while ensuring that the progenitors could produce high-ploidy Mks. We anticipate that subsequent optimization of cytokines for mature Mk production and delayed NIC addition will greatly increase high-ploidy Mk production.

摘要

背景目的

巨核细胞生成包括造血干细胞和祖细胞(HSPC)向巨核细胞(Mk)谱系的定向分化、Mk 祖细胞和成熟 Mk 的扩增、多倍体化和血小板释放。pH 值和氧分压从骨内膜到窦状隙逐渐增加,不同的细胞因子对于分化的不同阶段很重要。我们假设,在骨髓中模拟 Mk 分化过程中的变化条件,将有助于祖细胞的扩增,从而产生许多高倍体的 Mk。

方法

CD34+ HSPC 在 pH 值为 7.2 和 5% O2 条件下,与干细胞因子(SCF)、血小板生成素(Tpo)以及白细胞介素(IL)-3、IL-6、IL-11 和 Flt-3 配体的各种组合联合培养,以促进 Mk 祖细胞的扩增。用选定的细胞因子培养的细胞被转移到 pH 值为 7.4 和 20% O2 以生成成熟的 Mk,并使用烟酰胺(NIC)增强多倍体化。

结果

使用 Tpo + SCF + IL-3 + IL-11,我们从每个输入的 HSPC 中获得了 3.5 个 CD34+ CD41+ Mk 祖细胞,同时纯度从 1%提高到 17%。含有 IL-3 的细胞因子鸡尾酒产生了更多的祖细胞和成熟的 Mk,但纯度较低。在较高的 pH 值和氧分压下,Mk 的产生量更大。虽然祖细胞数量较少,但在第 5 天(而非第 7 天或第 9 天)将氧分压和 pH 值分别调整为 20%和 7.4,可产生最多的成熟 Mk,每个输入的 HSPC 可产生 14 个 Mk。NIC 将高倍体 Mk 的比例增加了一倍多,达到 40%。

结论

我们获得了广泛的 Mk 祖细胞扩增,同时确保祖细胞能够产生高倍体的 Mk。我们预计,随后对成熟 Mk 生成的细胞因子进行优化,并延迟 NIC 的添加,将大大增加高倍体 Mk 的生成。

相似文献

1
Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential.受骨髓龛启发的巨核细胞祖细胞的多相扩增,具有高多倍体化潜力。
Cytotherapy. 2010 Oct;12(6):767-82. doi: 10.3109/14653241003786148.
2
Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.三阶段体外扩增高倍体巨核细胞:实现大规模血小板生产。
Tissue Eng Part A. 2013 Apr;19(7-8):998-1014. doi: 10.1089/ten.TEA.2011.0111. Epub 2013 Jan 14.
3
Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.在血小板生成素以及有限量的干细胞因子和Flt-3配体存在的情况下,人脐带血富集CD34+细胞的巨核细胞在体外优先扩增。
J Hematother Stem Cell Res. 2003 Apr;12(2):179-88. doi: 10.1089/152581603321628322.
4
Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.巨核细胞祖细胞的体外扩增:多种生长因子组合对来自骨髓和粒细胞集落刺激因子动员的外周血的CD34+祖细胞的影响。
Exp Hematol. 1997 Oct;25(11):1125-39.
5
Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts.细胞因子诱导的人CD34+干/祖细胞和培养于正常成骨细胞上的CD34+CD41+早期巨核细胞骨髓细胞的扩增。
Stem Cells. 1999;17(2):92-9. doi: 10.1002/stem.170092.
6
Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.巨核细胞祖细胞的体外扩增:脐血与动员外周血的比较
Stem Cells Dev. 2005 Aug;14(4):415-24. doi: 10.1089/scd.2005.14.415.
7
The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.Mpl配体或血小板生成素或巨核细胞生长与分化因子对人巨核细胞祖细胞具有直接的增殖和分化活性。
Blood. 1995 Oct 1;86(7):2516-25.
8
The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3.人类巨核细胞的发育:III. 在合成培养基中由高度纯化的定向祖细胞发育成熟巨核细胞以及白细胞介素-3对血小板生成素诱导的多倍体化的抑制作用
Blood. 1997 Jan 15;89(2):426-34.
9
Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells.从富集的外周血CD34+细胞中对CD34+/CD41+晚期祖细胞进行体外扩增。
Ann Hematol. 2000 Jan;79(1):13-9. doi: 10.1007/s002770050003.
10
Enabling Large-Scale Ex Vivo Production of Megakaryocytes from CD34 Cells Using Gas-Permeable Surfaces.利用透气表面从 CD34 细胞体外大规模生成巨核细胞。
Stem Cells Transl Med. 2019 Jul;8(7):658-670. doi: 10.1002/sctm.18-0160. Epub 2019 Mar 8.

引用本文的文献

1
Similar but distinct: The impact of biomechanical forces and culture age on the production, cargo loading, and biological efficacy of human megakaryocytic extracellular vesicles for applications in cell and gene therapies.相似却又不同:生物力学力和培养时间对用于细胞和基因治疗的人巨核细胞外泌体的产生、货物装载及生物学功效的影响
Bioeng Transl Med. 2023 Jun 22;8(5):e10563. doi: 10.1002/btm2.10563. eCollection 2023 Sep.
2
Inhibition of Tropomyosin Receptor Kinase A Signaling Negatively Regulates Megakaryopoiesis and induces Thrombopoiesis.抑制原肌球蛋白受体激酶 A 信号通路可负向调节巨核细胞生成并诱导血小板生成。
Sci Rep. 2019 Feb 26;9(1):2781. doi: 10.1038/s41598-019-39385-x.
3
In vitro culture of murine megakaryocytes from fetal liver-derived hematopoietic stem cells.从胎肝来源的造血干细胞中体外培养巨核细胞。
Platelets. 2018 Sep;29(6):583-588. doi: 10.1080/09537104.2018.1492107. Epub 2018 Jul 26.
4
Platelet bioreactor-on-a-chip.芯片上的血小板生物反应器
Blood. 2014 Sep 18;124(12):1857-67. doi: 10.1182/blood-2014-05-574913.
5
The incredible journey: From megakaryocyte development to platelet formation.从巨核细胞发育到血小板形成:不可思议的旅程。
J Cell Biol. 2013 Jun 10;201(6):785-96. doi: 10.1083/jcb.201304054.
6
Challenges and promises for the development of donor-independent platelet transfusions.供者无关性血小板输注的发展挑战与前景
Blood. 2013 Apr 25;121(17):3319-24. doi: 10.1182/blood-2012-09-455428. Epub 2013 Jan 15.
7
Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.三阶段体外扩增高倍体巨核细胞:实现大规模血小板生产。
Tissue Eng Part A. 2013 Apr;19(7-8):998-1014. doi: 10.1089/ten.TEA.2011.0111. Epub 2013 Jan 14.

本文引用的文献

1
Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition.烟酰胺对巨核细胞多倍体化影响的机制研究以及NAD +水平和SIRT抑制的作用
Exp Hematol. 2009 Nov;37(11):1340-1352.e3. doi: 10.1016/j.exphem.2009.08.004. Epub 2009 Aug 26.
2
Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents.化疗诱导的血小板减少症的管理:血小板生成药物的现状
Semin Hematol. 2009 Jan;46(1 Suppl 2):S26-32. doi: 10.1053/j.seminhematol.2008.12.007.
3
Design, characterization and application of a minibioreactor for the culture of human hematopoietic cells under controlled conditions.设计、表征和应用一种小型生物反应器,以在控制条件下培养人造血细胞。
Cytotechnology. 1998 Nov;28(1-3):127-38. doi: 10.1023/A:1008042000744.
4
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes.黏附受体、细胞外蛋白和肌球蛋白IIA协同作用,调控人类巨核细胞的前血小板形成。
J Thromb Haemost. 2008 Nov;6(11):1900-7. doi: 10.1111/j.1538-7836.2008.03132.x. Epub 2008 Aug 22.
5
AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.AKR-501(YM477)与血小板生成素联合使用可增强人类巨核细胞生成。
Exp Hematol. 2008 Oct;36(10):1337-42. doi: 10.1016/j.exphem.2008.04.020. Epub 2008 Jul 10.
6
Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors.通过ES囊泡(一种聚集造血祖细胞的VEGF促进形成的结构)在体外从人胚胎干细胞生成功能性血小板。
Blood. 2008 Jun 1;111(11):5298-306. doi: 10.1182/blood-2007-10-117622. Epub 2008 Apr 3.
7
Increased production of megakaryocytes near purity from cord blood CD34+ cells using a short two-phase culture system.使用短的两阶段培养系统从脐带血CD34+细胞中近乎纯地增加巨核细胞的产量。
J Immunol Methods. 2008 Mar 20;332(1-2):82-91. doi: 10.1016/j.jim.2007.12.015. Epub 2008 Jan 18.
8
Transplantation of human peripheral blood CD34-positive cells in combination with ex vivo generated megakaryocytes results in fast platelet formation in NOD/SCID mice.将人外周血CD34阳性细胞与体外生成的巨核细胞联合移植,可使NOD/SCID小鼠快速形成血小板。
Leukemia. 2008 Jan;22(1):203-8. doi: 10.1038/sj.leu.2404979. Epub 2007 Oct 18.
9
Platelet transfusions.血小板输注
Lancet. 2007 Aug 4;370(9585):427-38. doi: 10.1016/S0140-6736(07)61198-2.
10
From hematopoietic stem cells to platelets.从造血干细胞到血小板。
J Thromb Haemost. 2007 Jul;5 Suppl 1:318-27. doi: 10.1111/j.1538-7836.2007.02472.x.